Reference : De l'inapplicabilite de certaines recommandations therapeutiques en pratique: l'exemp...
Scientific journals : Article
Human health sciences : Pharmacy, pharmacology & toxicology
De l'inapplicabilite de certaines recommandations therapeutiques en pratique: l'exemple du remboursement des medicaments hypolipidemiants en Belgique.
[fr] On the inapplicability of certain therapeutic guidelines in practice: the example of reimbursement for hypolipidemic agents in Belgium
Scheen, André mailto [Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
Revue Médicale de Liège
Hopital de Baviere
Yes (verified by ORBi)
[en] Anticholesteremic Agents/economics/therapeutic use ; Belgium ; Cost-Benefit Analysis ; Drug Costs ; Economics, Pharmaceutical ; Evidence-Based Medicine ; Health Policy ; Humans ; Hypercholesterolemia/drug therapy ; Insurance Coverage ; Insurance, Health, Reimbursement
[en] International guidelines from the Task Force of European and other Societies on Coronary Prevention and national guidelines from the Belgian Lipid Club recently emphasized the potential interest of adequate management of patients with even moderate hypercholesterolaemia. However, current criteria for the reimbursement of lipid-lowering drugs in Belgium do not allow to follow these guidelines. A solution should be urgently found in order to bridge the gap and permit practitioners, after diet failure, to effectively prescribe lipid-lowering agents in patients who should benefit in priority of such a treatment. It is certainly the case in secondary prevention as well as, in high risk individuals, in primary prevention, i.e. in situations where these drugs have provided enough evidence of their efficacy with an acceptable cost-benefit ratio.

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.